Author
Share this page:
Tag Archives: Cirrhosis
What are the Effects of Albumin in Patients With SBP?
Albumin infusion prevents renal impairment and reduces mortality among patients with spontaneous bacterial peritonitis (SBP), according to a meta-analysis published in the February issue of Clinical Gastroenterology and Hepatology. SBP is a common bacterial infection among cirrhotic patients and a … Continue reading
Posted in Practice
Tagged ascites, bacterial infection, blood volume, Cirrhosis, complication, hepatitis, immune response, Inflammation, kidney, liver disease, nephrology, therapy, treatment
1 Comment
New Ways to Study HCV, Genotypes 3 and 4
Researchers can now study replication of Hepatitis C virus genotypes 3 and 4 in cultured cells, described in 2 articles in the January issue of Gastroenterology. These new tools will improve our understanding of how they cause liver disease, and … Continue reading
Posted in Basic Science, Practice
Tagged antiviral, assay, Cirrhosis, DAA, drug testing, experimental system, HCV, hepatitis C virus, in vitro, laboratory, liver disease, model, replication
2 Comments
Can We Prevent Portal Vein Thrombosis in Patients With Cirrhosis?
The anti-clotting agent enoxaparin prevents portal vein thrombosis (PVT) in patients with cirrhosis, according to the November issue of Gastroenterology. PVT can lead to portal hypertension and reduce the blood supply to the liver—some patients with acute or extensive PVT develop severe gastrointestinal … Continue reading
Differences in HCV Infection, and Effects of Treatment, Among Countries
Hepatitis C virus (HCV) infections have developed and spread at different rates in different countries, affecting outcomes of therapy, according to the October issue of Gastroenterology. Specific details of each population must therefore be considered in designing prevention and treatment … Continue reading
Posted in Basic Science, Practice
Tagged Cirrhosis, disease progression, Epidemiology, Europe, Fibrosis, hepatitis, Liver Cancer, liver disease, transplant, United States
Leave a comment
How Common is Portal Hypertension in Patients With NAFLD?
Patients with nonalcoholic fatty liver disease (NAFLD) are at risk for portal hypertension and esophageal varices, according to the September issue of Clinical Gastroenterology and Hepatology. The study also shows that factors such as advanced liver disease, type 2 diabetes, … Continue reading
Posted in Practice
Tagged Cirrhosis, disease progression, fatty liver disease, Fibrosis, Inflammation, liver disease, NAFLD, NASH, Obesity, Prevention, risk factor
1 Comment
It’s Not Easy to Diagnose Intermediate-Stage Liver Fibrosis
Biopsy has a low level of diagnostic performance for liver fibrosis stages F2 and F1. The recommendation for biopsy analysis, instead of non-invasive tests, for diagnosis of intermediate stages of fibrosis is therefore misleading, according to the June issue of … Continue reading
Posted in Practice
Tagged Cirrhosis, diagnostic, HBV, HCV, hepatitis progression, Inflammation, liver disease, pathology anlysis, prognostis, response to therapy, testing
1 Comment
A Special Issue on Viral Hepatitis
The May issue of Gastroenterology features a very special supplement—“Viral Hepatitis: A Changing Field”—comprising 17 review and commentary articles from international leaders in hepatitis treatment and research. The issue provides insight into the rapid progress made in the treatment and … Continue reading
Posted in Basic Science, Practice
Tagged Cirrhosis, editorial, HAV, HBV, HCV, hepatitis, HEV, perspective, review, therapy, treatment, Virology
2 Comments
Is Cardiac Surgery Safe for Patients With Cirrhosis?
Patients with compensated cirrhosis who undergo cardiac surgery with cardiopulmonary bypass do not have greater post-operative mortality or morbidity than other patients who receive this surgery, according to the May issue of Clinical Gastroenterology and Hepatology. Advanced liver disease is … Continue reading
Posted in Practice
Tagged ascites, cardiac surgery, Cirrhosis, Complications, heart surgery, hepatic decompensation, liver disease, risk factors, safety, therapy, treatment
3 Comments
A Better Way to Make Pluripotent Cells From Liver Cells
Researchers have identified an efficient method for creating pluripotent stem cells from differentiated liver cells, according to the April issue of Gastroenterology. This technology could lead to new methods for therapeutic regeneration of diseased or damaged tissues. Embryonic stem cells … Continue reading
Why are Some Immunized Children Still At Risk for HBV Infection?
Despite immunization, children born to mothers with replicating HBV (marked by hepatitis B e antigen, or HBeAg) are still at risk for infection, according to the April issue of Gastroenterology. Mother-to-infant transmission is the major cause of hepatitis B virus … Continue reading
Posted in Basic Science, Practice
Tagged baby, Cirrhosis, HCC, hepatitis, mother to child transmission, mother-child, pediatric, Prevention, vaccination, vaccine
Leave a comment
Kristine Novak, PhD, Science Editor
